BSE filing, NSE: LYKISLTD. Summary written from the filing by ALFA Finder's alert engine.
Lykis Ltd: key numbers
- Share price
- ₹44.00
- Market cap
- ₹85.25 Cr
- Revenue (annual)
- ₹392.8 Cr
- Net profit (annual)
- ₹6.48 Cr
- P/E (TTM)
- 7.9×Sector 38.3×
- Promoter holding
- 67.17%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lykis Ltd
All →Krowniq Board Meeting Date
KROWNIQ Ltd will hold a board meeting on 4 November 2026 to approve H1 FY27 unaudited results and take on record the limited review report. The board will also consider appointing a Company Secretary, and trading window closure applies until 6 November 2026.
Krowniq Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).
Krowniq Management Change
Krowniq Limited announced the resignations of Chief Financial Officer Shrigopal Kandoi and Company Secretary Kinjal Rathod. Both executives cited personal reasons for their departures from the company.
Lykis Management Change
Krowniq Limited announced the resignation of Ms. Kinjal Rathod as Company Secretary and Compliance Officer, effective August 14, 2026.
Lykis Q1 FY27 Results: Turns Profitable, Net Profit ₹3.9 Cr
Lykis Ltd reported revenue from operations of ₹126.7 Cr (+88.5% YoY) and net profit of ₹3.9 Cr for Q1 FY27.
- Key figure
- Net profit ₹3.9 Cr
Lykis Merger & Restructuring
Krowniq Limited has completed the initial subscription to the share capital of its two wholly-owned subsidiaries, Parshav Infra Market and Exnora Trade. Operations will commence shortly.
Other other announcement announcements
All →Milky Mist Dairy Food Other Announcement
Milky Mist's board appointed B Chandra & Associates as Secretarial Auditors for FY 2026-27 to 2030-31. Shareholder approval is pending at the ensuing AGM.
- Execution
- FY 2026-27 to FY 2030-31 (five years)
Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd, an SME-platform listed company, confirms non-applicability of Corporate Governance under Regulation 27(2) for the quarter ended 30 September 2026. A Company Secretary certificate is enclosed.
Wipro Other Announcement
Wipro disclosed a designated person's 34,200-share ADR sale worth about ₹0.67 Crore on 28 October 2026. The sale followed RSU exercise, leaving 60,266 securities held.
- Value
- ₹0.67 Cr
OK Play India Other Announcement
OK Play India filed its quarterly shareholding pattern for the quarter ended September 2026. It shows category holdings only, with no transaction.
Spice Islands Industries Other Announcement
Spice Islands Industries filed a Reg 32 statement reporting no deviation in preferential issue fund utilization for Q3 FY27. The ₹8.70 Crore raise is fully deployed.
Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.